Cargando…

Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists

The μ‐opioid receptor (μOR) is the major target for opioid analgesics. Activation of μOR initiates signaling through G protein pathways as well as through β‐arrestin recruitment. μOR agonists that are biased towards G protein signaling pathways demonstrate diminished side effects. PZM21, discovered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haoqing, Hetzer, Florian, Huang, Weijiao, Qu, Qianhui, Meyerowitz, Justin, Kaindl, Jonas, Hübner, Harald, Skiniotis, Georgios, Kobilka, Brian K., Gmeiner, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322534/ https://www.ncbi.nlm.nih.gov/pubmed/35385593 http://dx.doi.org/10.1002/anie.202200269

Ejemplares similares

Structure of the μ Opioid Receptor-G(i) Protein Complex
por: Koehl, Antoine, et al.
Publicado: (2018)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Photochromic Fentanyl Derivatives for Controlled μ‐Opioid Receptor Activation
por: Lahmy, Ranit, et al.
Publicado: (2022)

Structural insights into μ-opioid receptor activation
por: Huang, Weijiao, et al.
Publicado: (2015)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Structure of the Neurotensin Receptor 1 in complex with β-arrestin 1
por: Huang, Weijiao, et al.
Publicado: (2020)

Influence of G protein-biased agonists of μ-opioid receptor on addiction-related behaviors
por: Kudla, Lucja, et al.
Publicado: (2021)

Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine‐Derived Phenylazocarboxamides as Novel μ‐Opioid Receptor Ligands
por: Krüll, Jasmin, et al.
Publicado: (2020)

Cryo-EM structure of the activated GLP-1 receptor in complex with G protein
por: Zhang, Yan, et al.
Publicado: (2017)

Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
por: Li, Xin, et al.
Publicado: (2017)

Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
por: Ye, Liang, et al.
Publicado: (2023)

[(18)F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor
por: Nebel, Natascha, et al.
Publicado: (2017)

Comparison of an Addictive Potential of μ-Opioid Receptor Agonists with G Protein Bias: Behavioral and Molecular Modeling Studies
por: Kudla, Lucja, et al.
Publicado: (2021)

Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
por: Manglik, Aashish, et al.
Publicado: (2012)

Structures of Gα Proteins in Complex with Their Chaperone Reveal Quality Control Mechanisms
por: Seven, Alpay Burak, et al.
Publicado: (2020)

Selective and Wash‐Resistant Fluorescent Dihydrocodeinone Derivatives Allow Single‐Molecule Imaging of μ‐Opioid Receptor Dimerization
por: Gentzsch, Christian, et al.
Publicado: (2020)

Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor
por: Cong, Xiaojing, et al.
Publicado: (2015)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Pharmacological Characterization of Low-to-Moderate Affinity Opioid Receptor Agonists and Brain Imaging with (18)F-Labeled Derivatives in Rats
por: Ott, Julian, et al.
Publicado: (2020)

Computational Drug Design of Novel Agonists of the μ -Opioid Receptor to Inhibit Pain Signaling
por: Daoud, Nancy, et al.
Publicado: (2023)

Structural and dynamic insights into supra-physiological activation and allosteric modulation of a muscarinic acetylcholine receptor
por: Xu, Jun, et al.
Publicado: (2023)

Structure-guided development of heterodimer-selective GPCR ligands
por: Hübner, Harald, et al.
Publicado: (2016)

The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist
por: Montes, Guilherme Carneiro, et al.
Publicado: (2017)

The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist
por: Gassaway, M M, et al.
Publicado: (2014)

Constrained catecholamines gain β(2)AR selectivity through allosteric effects on pocket dynamics
por: Xu, Xinyu, et al.
Publicado: (2023)

Author Correction: Constrained catecholamines gain β(2)AR selectivity through allosteric effects on pocket dynamics
por: Xu, Xinyu, et al.
Publicado: (2023)

Conformational dynamics of the μ-opioid receptor determine ligand intrinsic efficacy
por: Zhao, Jiawei, et al.
Publicado: (2023)

Delineating the Ligand–Receptor Interactions That Lead to Biased Signaling at the μ-Opioid Receptor
por: Kelly, Brendan, et al.
Publicado: (2021)

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2020)

A Facile Synthesis for Novel Loperamide Analogs as Potential μ Opioid Receptor Agonists
por: Bao, Xiaofeng, et al.
Publicado: (2012)

The partial µ-opioid agonist buprenorphine in autism spectrum disorder: a case report
por: Skoglund, Charlotte, et al.
Publicado: (2022)

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists
por: Dumitrascuta, Maria, et al.
Publicado: (2020)

Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database
por: Sommer, Thomas, et al.
Publicado: (2017)

Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
por: Li, Zoe, et al.
Publicado: (2023)

Effect of Tramadol (μ-opioid receptor agonist) on orthodontic tooth movements in a rat model
por: Rashidpour, M., et al.
Publicado: (2012)

Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine
por: Webster, Lynn, et al.
Publicado: (2016)

The novel μ‐opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
por: Hill, Rob, et al.
Publicado: (2018)

Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands
por: Wu, Zhijun, et al.
Publicado: (2019)

A tetrapeptide class of biased analgesics from an Australian fungus targets the µ-opioid receptor
por: Dekan, Zoltan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8jpjr9bi8p6d45jokro83n1ita